Recent Advances in the Treatment of Chronic GVHD: ASH 2024 - Episode 8

Challenges, Limitations, and Treatment Sequencing in Chronic GVHD

Panelists discuss the key challenges and limitations of existing therapies for graft-versusvs-host disease (GVHD), and explore current approaches to sequencing treatments, focusing on how to optimize patient outcomes while managing therapy-related risks.

EP. 1: Understanding Graft-VS-Host Disease (GVHD) Basics
EP. 2: Early Diagnosis and Intervention in GVHD Part 1
EP. 3: Early Diagnosis and Intervention in GVHD Part 2
EP. 4: Managing Skin Manifestations and Organ Involvement in GVHD
EP. 5: Treatment Decision-Making in Chronic GVHD
EP. 6: NCCN Guidelines and Clinical Updates in Chronic GVHD
EP. 7: FDA-Approved Therapies for Chronic GVHD
Now Viewing
EP. 8: Challenges, Limitations, and Treatment Sequencing in Chronic GVHD
EP. 9: Future Perspectives and Key Takeaways

Video content above is prompted by the following:

  • What are the key challenges and limitations of these existing therapies?
  • What is your current approach to sequencing?